Ciklazodon

Cyclazodone is a centrally acting stimulant developed in the 1960s, structurally related to pemoline and 4-methylaminorex. It appeared on the research chemical market in 2017 with limited pharmacological data. While animal studies suggest lower cardiotoxicity and hepatotoxicity than amphetamine, the structurally related pemoline was withdrawn due to causing liver damage in children. Heavy or sustained usage may result in liver damage. Use accurate scales, start with low doses, and employ harm reduction practices.

Also known as: Cyclazadone, Cyclopropylpemoline, N-cyclopropylpemoline, NCP-pemoline

Classification

Chemical: Aminorex
Psychoactive: Nootropic
Psychoactive: Stimulant
Tag: 4-oxazolidinone
Tag: Oxazolinone
Tag: Research-Chemical
Tag: Aminorex

Effects

Stimulation
Physical Euphoria
Stamina Enhancement
Loss Of Appetite
Physical Energy
Teeth Grinding
Focus Enhancement
Motivation Enhancement
Wakefulness
Cognitive Euphoria
Analysis Enhancement
Thought Acceleration
Bodily Control Enhancement
Appetite Suppression
Increased Libido
Light Sensitivity
Increased Music Appreciation
Dehydration

Routes of Administration

Oral

Dosage

Threshold: 2–5 mg
Light: 5-10 mg
Common: 10-20 mg
Strong: 20-30 mg
Heavy: 35 mg+

Duration

Onset: 0.3-0.8 h
Comeup: 0.5-1 h
Peak: 2-4 h
Offset: 1-2 h
After Effects: 1-12 h
Total Duration: 5-8 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu